Wu, D., Liu, Z., Wang, Y., Zhang, Q., Li, J., Zhong, P., . . . Li, Y. (2021). Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway. Oxid Med Cell Longev.

Wu, Dongdong, Zhengguo Liu, Yizhen Wang, Qianqian Zhang, Jianmei Li, Peiyu Zhong, Zhongwen Xie, Ailing Ji, and Yanzhang Li. "Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease Via Inhibition of Apoptosis and Promotion of Autophagy Through the ROS/MAPK Signaling Pathway." Oxid Med Cell Longev 2021.

Wu, Dongdong, et al. "Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease Via Inhibition of Apoptosis and Promotion of Autophagy Through the ROS/MAPK Signaling Pathway." Oxid Med Cell Longev 2021.